David Neil Hayes
Oprichter bij GeneCentric Therapeutics, Inc.
Actieve functies van David Neil Hayes
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Directeur/Bestuurslid | - | - |
| Oprichter | 01-01-2011 | - | |
North Carolina Cancer Hospital
 North Carolina Cancer Hospital Hospital/Nursing ManagementHealth Services The North Carolina Cancer Hospital is a cancer research and treatment center located at the University of North Carolina at Chapel Hill. The American company serves patients at the N.C. Cancer Hospital. | Corporate Officer/Principal | - | - |
Loopbaan van David Neil Hayes
Opleiding van David Neil Hayes
| The University of North Carolina at Charlotte | Doctorate Degree |
| Davidson College | Undergraduate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Director/Board Member | 1 |
| Founder | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
North Carolina Cancer Hospital
North Carolina Cancer Hospital Hospital/Nursing ManagementHealth Services The North Carolina Cancer Hospital is a cancer research and treatment center located at the University of North Carolina at Chapel Hill. The American company serves patients at the N.C. Cancer Hospital. | Health Services |
- Beurs
- Insiders
- David Neil Hayes
- Ervaring
